A Rac1/Cdc42 GTPase-Specific Small Molecule Inhibitor Suppresses Growth of Primary Human Prostate Cancer Xenografts and Prolongs Survival in Mice

Karin Zins(Medical University of Vienna), Seyedhossein Aharinejad(Medical University of Vienna)

PLoS ONE

September 11, 2013

10.1371/journal.pone.0074924

Cited by 95

Related Papers

Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity

|Journal of Translational Medicine|2013|67

Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes

|Oncotarget|2018|36